Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Myo-inositol with magnesium effectively reduces acne and hirsutism in PCOS patients without side effects.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Women with PCOS and androgenic alopecia have different triglyceride metabolism compared to those without hair loss.

Mice with human gene experienced hair loss when treated with DHT.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Androgens can both increase body hair and cause scalp hair loss.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.

Androgens slow hair growth by altering Wnt signaling in balding cells.

Androgens increase a growth factor in hair cells by creating reactive oxygen species, and antioxidants might help treat hair loss.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

Beard cells, unlike scalp cells, produce growth factors in response to testosterone, which may explain differences in hair growth.

RU 58841 may treat acne, hair loss, and excessive hair growth.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Hair loss from genetics and hormones can be treated with drugs or surgery.

AMT may cause hair loss and changing dWAT activity could help treat it.